5225 Results

People

  1. Giralt
    Giralt
  2. Hellmann
    Hellmann
  3. Ladanyi
    Ladanyi
  4. Motzer
    Motzer
  5. Lee
    Lee
  6. Arcila
    Arcila
  7. Berger
    Berger
  8. Hyman
    Hyman
  9. Drilon
    Drilon
  10. Levine
    Levine

Groups

  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)
  7. Survivorship Research (854)
  8. Hematologic Malignancies, Division of (789)
  9. Population Sciences Research Program (691)
  10. Department of Pathology and Laboratory Medicine (685)
  1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes among young small cell lung cancer (SCLC) patients and insurance status: A SEER analysis 2007-2014
    Meeting Abstract

    Wang, Q.; Zhang, Y.; Jiang, C.; Kunte, S.; Gupta, M.; Deng, L.; Xiao, Z.; Liu, Y.; Perimbeti, S.; Daly, R. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Updated efficacy and safety of KEYNOTE-052: A single-arm phase 2 study investigating first-line pembrolizumab (pembro) in cisplatin-ineligible advanced urothelial cancer (UC)
    Meeting Abstract

    Vuky, J.; Balar, A. V.; Castellano, D. E.; O'Donnell, P. H.; Grivas, P.; Bellmunt, J.; Powles, T.; Bajorin, D. F.; Hahn, N. M.; De Wit, R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neurologic morbidities, psychological distress, and functional independence in adult survivors of childhood cancer treated with CNS-directed therapies: A report from the Childhood Cancer Survivor Study
    Meeting Abstract

    Vuotto, S. C.; Krull, K. R.; Li, C.; Okcu, M. F.; Bowers, D. C.; Ullrich, N. J.; Srivastava, D.; Howell, R. M.; Gibson, T. M.; Leisenring, W. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of PLX9486 alone and in combination (combo) with the KIT inhibitors pexidartinib (pexi) or sunitinib (su) in patients (Pts) with advanced solid tumors and gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Wagner, A. J.; Tap, W. D.; Shields, A. F.; Patnaik, A.; Chugh, R.; Tinoco, G.; Michelson, G.; Alcantar, O.; Pelayo, M.; Zhang, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Correlation of degree of tumor immune infiltration and insertion-and-deletion (indel) burden with outcome on programmed death 1 (PD1) therapy in advanced renal cell cancer (RCC)
    Meeting Abstract

    Voss, M. H.; Novik, J. B.; Hellmann, M. D.; Ball, M.; Hakimi, A. A.; Miao, D.; Margolis, C.; Horak, C.; Wind-Rotolo, M.; De Velasco, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Characterizing tumor immune microenvironment (TME) and outcomes for 409 patients (pts) treated on COMPARZ: Distinct clusters emphasize immune infiltration vs. angiogenesis
    Meeting Abstract

    Voss, M. H.; Kuo, F.; Sanchez, A.; Ostrovnaya, I.; Cheng, Y.; Patel, P.; Marker, M.; Reising, A.; Chan, T. A. T.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results
    Meeting Abstract

    Villalobos, V. M.; Redondo, A.; Van Tine, B. A.; Schwartz, G. K.; Dickson, M. A.; Chmielowski, B.; Peterson, P.; Cronier, D.; Wright, J. A.; Attia, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of SLCO1B3 single nucleotide polymorphisms (SNPs) on outcomes in patients with castration resistant prostate cancer (CRPC) treated with docetaxel
    Meeting Abstract

    Tripathi, A.; Xie, W.; Sweeney, C.; Choudhury, A. D.; Pomerantz, M.; Wei, X. X.; Taplin, M. E.; Choueiri, T. K.; Lee, G. S. M.; Kantoff, P. W.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs. treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC)
    Meeting Abstract

    Tripathy, D.; Tolaney, S. M.; Seidman, A. D.; Anders, C. K.; Ibrahim, N. K.; Rugo, H. S.; Twelves, C.; DieĢras, V.; Mueller, V.; Hannah, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (OlympiAD): Efficacy in patients with visceral metastases
    Meeting Abstract

    Tung, N. M.; Im, S. A.; Senkus-Konefka, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Li, W.; Armstrong, A. C.; Conte, P. F.; Wu, W.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save